Venture capital with a European twist: Cultural factors suggest that european venture capitalists will follow a different model than their US counterparts in selecting companies to fund

Nature Biotechnology

Volumn 17, Issue 3s, 1999, Pages B23-B24

  Frank, Lone ^b   Tscherning, Thomas ^a   Schönharting, Florian ^a  

^a BankInvest Biomedical Development   (Denmark)

^b NONE   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84984776350     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/9098     Document Type: Article

References (0)